The mortality rate for liver malignant neoplasms among Canadian men, standardized to per hundred thousand, shows a gradual upward trend from 2024 through 2028. Starting at 12.2 in 2024, it is projected to reach 12.7 by 2028. This indicates a modest year-on-year increase, averaging approximately 0.8% annually over the five-year period starting from 2024. The data suggests a consistent slight rise in mortality rates annually.
Future trends to watch for include:
- Advancements in early detection and treatment that could impact mortality rates.
- Potential public health interventions addressing risk factors such as hepatitis infections and alcohol consumption.
- Genetic and biomarker research developments that might influence prevention strategies.
